Cover Image
市場調查報告書

止血劑的全球市場 - 至2020年的預測:產品的種類 (凝血酶、氧化再生纖維素、並用、明膠、膠原蛋白) 、各地區

Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 352591
出版日期 內容資訊 英文 161 Pages
訂單完成後即時交付
價格
Back to Top
止血劑的全球市場 - 至2020年的預測:產品的種類 (凝血酶、氧化再生纖維素、並用、明膠、膠原蛋白) 、各地區 Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020
出版日期: 2016年02月16日 內容資訊: 英文 161 Pages
簡介

全球止血劑市場,預計2015年∼2020年以6.2%的成長,至2020年達到27億6千萬美元。

本報告提供全球止血劑市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 推動市場要素與阻礙要素
  • 主要的市場動態

第5章 止血劑市場:各類型產品

  • 簡介
    • 凝血酶
    • 氧化再生纖維素
    • 並用止血劑
    • 明膠
    • 膠原蛋白

第6章 止血劑市場:各地區

  • 簡介
  • 南北美洲
  • 歐洲
  • 亞太地區
  • 中東、非洲

第7章 競爭情形

  • 企業佔有率分析
  • 產品銷售
  • M&A
  • 合作、合資企業契約、擴張、夥伴關係
  • 核准、聯盟、重新配置、許可證、新品牌策略

第8章 止血劑市場:各企業

  • 簡介
  • JOHNSON & JOHNSON SERVICES, INC.
  • C. R. BARD, INC.
  • BAXTER
  • B. BRAUN MELSUNGEN AG
  • PFIZER INC.
  • VASCULAR SOLUTIONS, INC.
  • GELITA MEDICAL GMBH
  • EQUIMEDICAL
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • Z-MEDICA, LLC
  • MARINE POLYMER TECHNOLOGIES, INC.

第9章 附錄

圖表

目錄
Product Code: MD 4093

The global hemostats market size is projected to reach USD 2.76 billion by 2020, at a CAGR of 6.2% during from 2015 to 2020. Increasing number of surgery procedures and increasing number of insurance providers to bear the high cost of this medical devices like hemostats products, are the major factors influencing the growth of this market.

The administration and monitoring of hemostats during surgical procedures is a complex task for clinicians, as it depends upon the blood flow from the particular area of surgery. The usage of hemostats have no adverse effects and is an important procedure to prevent blood loss in patients, especially among the aging population. The market for hemostats is rapidly increasing with technological advancements and increasing number of surgeries. Also, hospitals and healthcare facilities are gradually increasing, supported by government which in turn is driving the growth of the hemostats market.

Hemostats is one of the sub-markets of wound closure devices. Over the years, these products have been used during surgeries to stop bleeding within a short span of time. These products are biodegradable, absorbable, and cost-effective. They have a tenure of maximum 2 years with no adverse effects.

Based on product type, this market is segmented into thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats, thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats.

Based on geography, the global hemostats market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis, market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities for the global Hemostats market.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:

  • Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global hemostats market are provided.
  • Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for hemostats across various regions, exploit new distribution channels, new clientele base, and different pricing policies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global hemostats market is provided. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided.
  • Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2020 is provided.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET SEGMENTATION & COVERAGE
  • 1.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTEGRATED ECOSYSTEM OF THE HEMOSTATS MARKET
    • 2.1.1. TOP-DOWN APPROACH
    • 2.1.2. BOTTOM-UP APPROACH
    • 2.1.3. MACRO INDICATOR- BASED APPROACH
    • 2.1.4. UNIT PRICE ANALYSIS
    • 2.1.5. PRODUCT MATRIX
    • 2.1.6. PORTER'S FIVE FORCES MODEL
    • 2.1.7. LIFE EXPECTANCY RATE
  • 2.2. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. MARKET DRIVERS AND INHIBITORS
  • 4.3. KEY MARKET DYNAMICS

5. HEMOSTATS MARKET, BY PRODUCT TYPE

  • 5.1. INTRODUCTION
    • 5.1.1. THROMBIN BASED HEMOSTATS
    • 5.1.2. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS
    • 5.1.3. COMBINATION HEMOSTATS
    • 5.1.4. GELATIN BASED HEMOSTATS
    • 5.1.5. COLLAGEN BASED HEMOSTATS

6. HEMOSTATS MARKET, BY GEOGRAPHY

  • 6.1. INTRODUCTION
  • 6.2. AMERICAS
    • 6.2.1. U.S.
    • 6.2.2. CANADA
    • 6.2.3. MEXICO
    • 6.2.4. BRAZIL
    • 6.2.5. ARGENTINA
    • 6.2.6. CHILE
    • 6.2.7. COLOMBIA
    • 6.2.8. PARAGUAY
    • 6.2.9. URUGUAY
  • 6.3. EUROPE
    • 6.3.1. GERMANY
    • 6.3.2. FRANCE
    • 6.3.3. U.K.
    • 6.3.4. ITALY
    • 6.3.5. SPAIN
    • 6.3.6. RUSSIA
    • 6.3.7. SWITZERLAND
    • 6.3.8. THE NETHERLANDS
    • 6.3.9. BELGIUM
    • 6.3.10. DENMARK
    • 6.3.11. TURKEY
  • 6.4. ASIA-PACIFIC
    • 6.4.1. JAPAN
    • 6.4.2. CHINA
    • 6.4.3. INDIA
    • 6.4.4. AUSTRALIA
    • 6.4.5. REPUBLIC OF KOREA
    • 6.4.6. THAILAND
    • 6.4.7. SINGAPORE
    • 6.4.8. VIETNAM
    • 6.4.9. TAIWAN
    • 6.4.10. MALAYSIA
    • 6.4.11. INDONESIA
    • 6.4.12. NEW ZEALAND
  • 6.5. MIDDLE EAST & AFRICA (MEA)
    • 6.5.1. EGYPT
    • 6.5.2. SAUDI ARABIA
    • 6.5.3. UAE
    • 6.5.4. ISRAEL
    • 6.5.5. OMAN
    • 6.5.6. KUWAIT
    • 6.5.7. ZIMBABWE
    • 6.5.8. KENYA
    • 6.5.9. JORDAN
    • 6.5.10. ALGERIA
    • 6.5.11. MOROCCO
    • 6.5.12. LIBYA
    • 6.5.13. TUNISIA
    • 6.5.14. SUDAN
    • 6.5.15. SOUTH AFRICA
    • 6.5.16. MAURITIUS

7. COMPETITIVE LANDSCAPE

  • 7.1. COMPANY SHARE ANALYSIS
    • 7.1.1. U.S
    • 7.1.2. CANADA
    • 7.1.3. BRAZIL
    • 7.1.4. GERMANY
    • 7.1.5. FRANCE
    • 7.1.6. U.K.
    • 7.1.7. CHINA
    • 7.1.8. INDIA
    • 7.1.9. JAPAN
  • 7.2. PRODUCT LAUNCHES
  • 7.3. MERGERS AND ACQUISITIONS
  • 7.4. COLLABORATIONS, JOINT AGREEMENTS & EXPANSIONS, PARTNERSHIPS
  • 7.5. APPROVALS, ALLIANCES, RELOCATIONS & LICENSING, AND NEW BRAND STRATEGY

8. HEMOSTATS MARKET, BY COMPANY

  • 8.1. JOHNSON & JOHNSON SERVICES, INC.
    • 8.1.1. BUSINESS OVERVIEW
    • 8.1.2. KEY FINANCIALS
    • 8.1.3. PRODUCT AND SERVICE OFFERINGS
    • 8.1.4. RELATED DEVELOPMENTS
    • 8.1.5. MNM VIEW
  • 8.2. C. R. BARD, INC.
    • 8.2.1. BUSINESS OVERVIEW
    • 8.2.2. KEY FINANCIALS
    • 8.2.3. PRODUCT AND SERVICE OFFERINGS
    • 8.2.4. RELATED DEVELOPMENTS
    • 8.2.5. MNM VIEW
  • 8.3. BAXTER
    • 8.3.1. OVERVIEW
    • 8.3.2. KEY FINANCIALS
    • 8.3.3. PRODUCT AND SERVICE OFFERINGS
    • 8.3.4. RELATED DEVELOPMENTS
    • 8.3.5. MNM VIEW
  • 8.4. B. BRAUN MELSUNGEN AG
    • 8.4.1. BUSINESS OVERVIEW
    • 8.4.2. KEY FINANCIALS
    • 8.4.3. PRODUCTS AND SERVICE OFFERINGS
    • 8.4.4. RECENT DEVELOPMENTS
    • 8.4.5. MNM VIEW
  • 8.5. PFIZER INC.
    • 8.5.1. BUSINESS OVERVIEW
    • 8.5.2. KEY FINANCIALS
    • 8.5.3. PRODUCTS AND SERVICE OFFERINGS
    • 8.5.4. RECENT DEVELOPMENTS
    • 8.5.5. MNM VIEW
  • 8.6. VASCULAR SOLUTIONS, INC.
    • 8.6.1. BUSINESS OVERVIEW
    • 8.6.2. KEY FINANCIALS
    • 8.6.3. PRODUCTS AND SERVICE OFFERINGS
    • 8.6.4. RECENT DEVELOPMENTS
    • 8.6.5. MNM VIEW
  • 8.7. GELITA MEDICAL GMBH
    • 8.7.1. BUSINESS OVERVIEW
    • 8.7.2. PRODUCTS AND SERVICE OFFERINGS
    • 8.7.3. RECENT DEVELOPMENTS
    • 8.7.4. MNM VIEW
  • 8.8. EQUIMEDICAL
    • 8.8.1. BUSINESS OVERVIEW
    • 8.8.2. PRODUCTS AND SERVICE OFFERINGS
    • 8.8.3. MNM VIEW
  • 8.9. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • 8.9.1. BUSINESS OVERVIEW
    • 8.9.2. KEY FINANCIALS
    • 8.9.3. PRODUCT AND SERVICE OFFERINGS
    • 8.9.4. MNM VIEW
  • 8.10. Z-MEDICA, LLC
    • 8.10.1. BUSINESS OVERVIEW
    • 8.10.2. PRODUCT AND SERVICE OFFERINGS
    • 8.10.3. RELATED DEVELOPMENTS
    • 8.10.4. MNM VIEW
  • 8.11. MARINE POLYMER TECHNOLOGIES, INC.
    • 8.11.1. BUSINESS OVERVIEW
    • 8.11.2. PRODUCT AND SERVICE OFFERINGS
    • 8.11.3. MNM VIEW

9. APPENDIX

  • 9.1. CUSTOMIZATION OPTIONS
    • 9.1.1. REGULATORY FRAMEWORK
    • 9.1.2. IMPACT ANALYSIS
  • 9.2. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 9.3. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: UNIT PRICE ANALYSIS
  • TABLE 2: HEMOSTATS MARKET: DRIVERS AND INHIBITORS
  • TABLE 3: HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 4: HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 5: COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 6: THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 7: GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 8: COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 9: OXIDIZED REGENERATION COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 10: HEMOSTATS MARKET, BY PRODUCT TYPE, 2013 - 2020 (USD MN)
  • TABLE 11: HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 12: THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 13: THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS)
  • TABLE 14: OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 15: OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS)
  • TABLE 16: COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 17: COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS)
  • TABLE 18: GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 19: GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS)
  • TABLE 20: COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN)
  • TABLE 21: COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS)
  • TABLE 22: HEMOSTATS MARKET, BY REGION, 2013-2020 (USD MN)
  • TABLE 23: AMERICAS HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN)
  • TABLE 24: AMERICAS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 25: U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 26: U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 27: U.S. HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 28: CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 29: CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 30: CANADA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 31: MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 32: MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 33: MEXICO HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 34: BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 35: BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 36: BRAZIL HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 37: ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 38: ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 39: ARGENTINA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 40: CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 41: CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 42: CHILE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 43: COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 44: COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 45: COLOMBIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 46: PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 47: PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 48: PARAGUAY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 49: URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 50: URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 51: URUGUAY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 52: EUROPE HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN)
  • TABLE 53: EUROPE HEMOSTATS MARKET VALUE, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 54: GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 55: GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 56: GERMANY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 57: FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 58: FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 59: FRANCE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 60: U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 61: U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 62: U.K. HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 63: ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 64: ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 65: ITALY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 66: SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 67: SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 68: SPAIN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 69: RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 70: RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 71: RUSSIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 72: SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 73: SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 74: SWITZERLAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 75: THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 76: THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 77: THE NETHERLANDS HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 78: BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 79: BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 80: BELGIUM HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 81: DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 82: DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 83: DENMARK HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 84: TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 85: TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 86: TURKEY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 87: ASIA-PACIFIC HEOMSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN)
  • TABLE 88: ASIA-PACIFIC HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 89: JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 90: JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 91: JAPAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 92: CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 93: CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 94: CHINA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 95: INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 96: INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 97: INDIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 98: AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 99: AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 100: AUSTRALIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 101: REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 102: REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 103: REPUBLIC OF KOREA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 104: THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 105: THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 106: THAILAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 107: SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 108: SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 109: SINGAPORE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 110: VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 111: VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 112: VIETNAM HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 113: TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 114: TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 115: TAIWAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 116: MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 117: MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 118: MALAYSIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 119: INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 120: INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 121: INDONESIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 122: NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 123: NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 124: NEW ZEALAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 125: MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN)
  • TABLE 126: MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 127: EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 128: EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 129: EGYPT HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 130: SAUDI ARABIA HEMOSTATS, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 131: SAUDI ARABIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 132: SAUDI ARABIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 133: UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 134: UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 135: UAE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 136: ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 137: ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 138: ISRAEL HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 139: OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 140: OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 141: OMAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 142: KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 143: KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 144: KUWAIT HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 145: ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 146: ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 147: ZIMBABWE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 148: KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 149: KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 150: KENYA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 151: JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 152: JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 153: JORDAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 154: ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 155: ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 156: ALGERIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 157: MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 158: MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 159: MOROCCO HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 160: LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 161: LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 162: LIBYA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 163: TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 164: TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 165: TUNISIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 166: SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 167: SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 168: SUDAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 169: SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 170: SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 171: SOUTH AFRICA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 172: MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • TABLE 173: MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 174: MAURITIUS HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD)
  • TABLE 175: HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 176: CANADA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 177: BRAZIL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 178: GERMANY HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 179: FRANCE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 180: U.K. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 181: CHINA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 182: INDIA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • TABLE 183: JAPAN HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014
  • TABLE 184: PRODUCT LAUNCHES
  • TABLE 185: MERGERS AND ACQUISITIONS
  • TABLE 186: COLLABORATIONS, JOINT AGREEMENTS & EXPANSIONS, PARTNERSHIPS
  • TABLE 187: APPROVALS, ALLIANCES, RELOCATION & LICENSING, AND NEW BRAND STRATEGY
  • TABLE 188: JOHNSON & JOHNSON SERVICES, INC.: REVENUE, BY BUSINESS SEGMENT, 2011-2014 (USD MN)
  • TABLE 189: JOHNSON & JOHNSON SERVICES, INC.: REVENUE, BY GEOGRAPHIC SEGMENT, 2011-2014 (USD MN)
  • TABLE 190: C. R. BARD, INC.: REVENUE, BY BUSINESS SEGMENTS, 2010-2014 (USD MN)
  • TABLE 191: BAXTER: REVENUE, BY BUSINESS SEGMENTS, 2010-2014 (USD MN)
  • TABLE 192: BAXTER: REVENUE, BY GEOGRAPHIC SEGMENT, 2010-2014 (USD MN)
  • TABLE 193: B. BRAUN MELSUNGEN AG: REVENUE, BY BUSINESSS SEGMENT, 2010-2014 (USD MN)
  • TABLE 194: B. BRAUN MELSUNGEN AG: REVENUE, BY GEOGRAPHIC SEGMENT, 2010-2014 (USD MN)
  • TABLE 195: PFIZER INC.: REVENUE MIX, 2010-2014 (USD MN)
  • TABLE 196: PFIZER INC.: REVENUE, BY GEOGRAPHIC SEGMENT 2010-2014 (USD MN)
  • TABLE 197: VASCULAR SOLUTIONS, INC.: REVENUE, BY SEGMENT, 2010-2014 (USD MN)
  • TABLE 198: VASCULAR SOLUTIONS, INC.: REVENUE, BY GEOGRAPHIC SEGMENT, 2010-2014 (USD MN)
  • TABLE 199: INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2011 - 2014 (USD MN)

LIST OF FIGURES

  • FIGURE 1: HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • FIGURE 2: HEMOSTATS MARKET: INTEGRATED ECOSYSTEM
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: MACRO INDICATOR-BASED APPROACH
  • FIGURE 6: LIFE EXPECTANCY RATE
  • FIGURE 7: HEMOSTATS MARKET SNAPSHOT 2014
  • FIGURE 8: HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 9: THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)
  • FIGURE 10: OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)
  • FIGURE 11: COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)
  • FIGURE 12: GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)
  • FIGURE 13: COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MN)
  • FIGURE 14: HEMOSTATS MARKET, BY REGION, 2015 & 2020 (USD MN)
  • FIGURE 15: AMERICAS HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN)
  • FIGURE 16: AMERICAS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 17: U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 18: CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 19: MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 20: BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 21: ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 22: CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 23: COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 24: PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 25: URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 26: EUROPE HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN)
  • FIGURE 27: EUROPE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 28: GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 29: FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 30: U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 31: ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 32: SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 33: RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 34: SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 35: THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 36: BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 37: DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 38: TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 39: ASIA-PACIFIC HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN)
  • FIGURE 40: ASIA-PACIFIC HEMOSTATS MARKET VALUE, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 41: JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 42: CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 43: INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 44: AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 45: REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 46: THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 47: SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 48: VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 49: TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 50: MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 51: INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 52: NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 53: MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY COUNTRY, 2014 & 2020 (USD MN)
  • FIGURE 54: MIDDLE EAST & AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 55: EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 56: SAUDI ARABIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 57: UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 58: ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 59: OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 60: KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 61: ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 62: KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 63: JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 64: ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 65: MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 66: LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 67: TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 68: SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 69: SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 & 2020 (USD MN)
  • FIGURE 70: MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN)
  • FIGURE 71: U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 72: CANADA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 73: BRAZIL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 74: GERMANY HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 75: FRANCE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 76: U.K. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 77: CHINA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 78: INDIA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 79: JAPAN HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
  • FIGURE 80: JOHNSON & JOHNSON SERVICES, INC: REVENUE MIX, 2014 (%)
  • FIGURE 81: JOHNSON & JOHNSON SERVICES, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 82: C. R. BARD, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 83: BAXTER: REVENUE MIX, 2014 (%)
  • FIGURE 84: BAXTER: REVENUE MIX, 2010-2014 (%)
  • FIGURE 85: B. BRAUN MELSUNGEN AG: REVENUE MIX, 2014 (%)
  • FIGURE 86: B. BRAUN MELSUNGEN AG.: REVENUE MIX, 2014 (%)
  • FIGURE 87: PFIZER INC.: -REVENUE MIX, 2014 (%)
  • FIGURE 88: VASCULAR SOLUTIONS, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 89: VASCULAR SOLUTIONS, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 90: INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE MIX, 2014 (%)
Back to Top